Abstract This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic. Lay Summary The SARS-CoV-19 virus and COVID-19 disease raise important questions about the risks to immunosuppressed IBD patients. We review the available data, including the SECURE IBD registry, and draw parallels to previous pandemics of influenza, SARs, and MERS. Graphical Abstract Graphical Abstract
【초록키워드】 COVID-19, SARS-CoV-2, pandemic, Influenza, severity, social isolation, SARS, Infection, risk, MERS, virus, COVID-19 disease, Health, Patient, Pandemics, Care, patients, IBD, risk of infection, Immunosuppressed, available data, symptomatic case, raise, provided, question, reducing, maintain, 【제목키워드】 SARS-CoV-2, IBD,